Dhanvantri Jeevan Rekha Ltd

ZDHJERKHealthcare Service Provider
24.90+0.00 (+0.00%)
As on 09 Feb 2026, 12:24 pmMarket Closed

Fundamental Score

...

Dhanvantri Jeevan Rekha Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

5.20%
Poor

Return on Capital Employed

5.82%
Poor

Operating Profit Margin (5Y)

3.31%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

94.50x

Market Capitalization

9.45 (Cr)

Industry P/E

39.28x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-182.35%
Poor

YoY Quarterly Sales Growth

7.75%
Poor

Sales Growth (5Y)

4.46%
Excellent

EPS Growth (5Y)

31.70%
Excellent

Profit Growth (5Y)

31.70%

Financial Health

Excellent

Debt to Equity

0.00x

Interest Coverage

N/A
Average

Free Cash Flow (5Y)

0.88 (Cr)

Ownership Structure

Poor

Promoter Holding

19.65%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
19.65%
Promoter Holding
9.45 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of ZDHJERK across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Excellent EPS Growth (31.70% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (31.70% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Debt-Free Balance Sheet (D/E: 0.00)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

11 factors identified

Below-Average Return on Equity (5.20%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (5.82%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.

Margin Pressure Concerns (3.31%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.

Premium Valuation Risk (P/E: 94.50x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Profit Decline Concern (-182.35%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes. Monitor for recovery signs and management guidance.

Limited Growth History (4.46% CAGR)

Observation: Below-average 5-year sales growth trajectory.

Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities. Assess future growth catalysts.

Low Promoter Commitment (19.65%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment and long-term vision alignment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Very High P/E Ratio

Observation: Significant overvaluation risk present.

Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Dhanvantri Jeevan Rekha Ltd

About ZDHJERK

Business Overview

Dhanvantri Jeevan Rekha Limited engages in the provision of medical and healthcare services in India. It offers diagnostic and therapeutic services. The company also provides specialty services, such as Cardiology, Gastroenterology, Neurology, Urology, Nephrology, Internal Medicine, Pulmonology, and other diagnostic services. In addition, the company operates a cath lab that provides angiography, angioplasty, pacemaker implantation, valvuloplasty services, etc. Dhanvantri Jeevan Rekha Limited was incorporated in 1993 and is based in Meerut, India.

Company Details

Symbol:ZDHJERK
Industry:Healthcare Service Provider
Sector:Healthcare Service Provider

Key Leadership

Ms. Shalini Sharma
MD & Director
General Bikram Singh (Retd.)
Chief Financial Officer
Ms. Ritika Bhandari
Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date
2011-09-15

ZDHJERK Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)5.20%
Return on Capital Employed5.82%
Operating Profit Margin (5Y)3.31%
Debt to Equity Ratio0.00
Interest Coverage RatioN/A

Growth & Valuation

Sales Growth (5Y)4.46%
Profit Growth (5Y)31.70%
EPS Growth (5Y)31.70%
YoY Quarterly Profit Growth-182.35%
YoY Quarterly Sales Growth7.75%

Frequently Asked Questions

What is the current price of Dhanvantri Jeevan Rekha Ltd (ZDHJERK)?

As of 09 Feb 2026, 12:24 pm IST, Dhanvantri Jeevan Rekha Ltd (ZDHJERK) is currently trading at ₹24.90. The stock has a market capitalization of ₹9.45 (Cr).

Is ZDHJERK share price Overvalued or Undervalued?

ZDHJERK is currently trading at a P/E ratio of 94.50x, compared to the industry average of 39.28x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the Dhanvantri Jeevan Rekha Ltd share price?

Key factors influencing ZDHJERK's price include its quarterly earnings growth (Sales Growth: 7.75%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Dhanvantri Jeevan Rekha Ltd a good stock for long-term investment?

Dhanvantri Jeevan Rekha Ltd shows a 5-year Profit Growth of 31.70% and an ROE of 5.20%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing.

How does Dhanvantri Jeevan Rekha Ltd compare with its industry peers?

Dhanvantri Jeevan Rekha Ltd competes with major peers in the Healthcare Service Provider. Investors should compare ZDHJERK's P/E of 94.50x and ROE of 5.20% against the industry averages to determine its competitive standing.

What is the P/E ratio of ZDHJERK and what does it mean?

ZDHJERK has a P/E ratio of 94.50x compared to the industry average of 39.28x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹95 for every ₹1 of annual earnings.

How is ZDHJERK performing according to Bull Run's analysis?

ZDHJERK has a Bull Run fundamental score of 23.9/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does ZDHJERK belong to?

ZDHJERK operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Dhanvantri Jeevan Rekha Ltd.

What is Return on Equity (ROE) and why is it important for ZDHJERK?

ZDHJERK has an ROE of 5.20%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Dhanvantri Jeevan Rekha Ltd generates profits from shareholders' equity.

How is ZDHJERK's debt-to-equity ratio and what does it indicate?

ZDHJERK has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.

What is ZDHJERK's dividend yield and is it a good dividend stock?

ZDHJERK offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has ZDHJERK grown over the past 5 years?

ZDHJERK has achieved 5-year growth rates of: Sales Growth 4.46%, Profit Growth 31.70%, and EPS Growth 31.70%.

What is the promoter holding in ZDHJERK and why does it matter?

Promoters hold 19.65% of ZDHJERK shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is ZDHJERK's market capitalization category?

ZDHJERK has a market capitalization of ₹9 crores, placing it in the Small-cap category.

How volatile is ZDHJERK stock?

ZDHJERK has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for ZDHJERK?

ZDHJERK has a 52-week high of ₹N/A and low of ₹N/A.

What is ZDHJERK's operating profit margin trend?

ZDHJERK has a 5-year average Operating Profit Margin (OPM) of 3.31%, indicating the company's operational efficiency.

How is ZDHJERK's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 7.75% and YoY Profit Growth of -182.35%.

What is the institutional holding pattern in ZDHJERK?

ZDHJERK has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.